Atopic Dermatitis Studies

Study 1

Therapeutics Clinical Research will be conducting a clinical research study on a naturally derived investigational product for control of Atopic Dermatitis

If you:

• Have atopic dermatitis (a type of eczema)
• Are 18 years of age or older

Qualified participants will receive at no cost:

• Study related medical examinations and testing
• Investigational study product (no placebo)

Compensation up to $300 for completing all visits of the study. If you're interested in finding out more about this clinical study, please contact Therapeutics Clinical Research at (619) 512-DERM (3376) or e-mail us at info@therapeuticsresearch.com

 

Study 2

Therapeutics Clinical Research is now enrolling a study to evaluate a topical investigational medication for pediatric patients with moderate to severe atopic dermatitis.

Key Inclusion Criteria:

• Children age 3 months to under 18 years of age
• Minimum weight of 8 pounds
• Clinical diagnosis of moderate to severe Atopic Dermatitis or Eczema (25% BSA)
• In general good health
• Willing to avoid constant sun exposure, tanning beds or other UV light sources
• If female is of child-bearing potential, she must have a negative urine pregnancy test and use an acceptable form of birth control (including abstinence0

Key Exclusion Criteria:

• Participation in another clinical research study
• Pregnant or lactating females
• Clinically infected Atopic Dermatitis
• Known history of Atopic Dermatitis that is unresponsive to topical steroids
• Any significant medical condition likely to interfere with evaluations, such as:
  • Skin disorders (i.e. Netherton's Syndrome, psoriasis, dermatologic fungal infections)
  • Pigmentation or extensive scarring in treatment areas
  • Significant Systemic Disease such as immunological deficiencies or HIV
  • Unstable medical disorders such as diabetes or hypertension
  • Life-threatening disease or current malignancies

If you're interested in finding out more about this clinical study, please contact Therapeutics Clinical Research at (619) 512-DERM (3376) or e-mail us at info@therapeuticsresearch.com

 

Study 3

Therapeutics Clinical Research is conducting a medical research study of an investigational topical product for volunteers with moderate to severe eczema or atopic dermatitis.

Key Inclusion Criteria:

• Adults, age 18 to 65
• General good health
• Moderate to severe atopic dermatitis for at least 12 months

Key Exclusion Criteria:

• Pregnant, planning a pregnancy or breastfeeding women
• Underlying medical problems such as liver disease, impaired kidney function or uncontrolled systemic disease
• Inability or unwillingness to undergo multiple venipunctures because of poor tolerability or lack of access to veins

If you're interested in finding out more about this clinical study, please contact Therapeutics Clinical Research at (619) 512-DERM (3376) or e-mail us at info@therapeuticsresearch.com